Your browser doesn't support javascript.
loading
Impact of pretreatment dihydropyrimidine dehydrogenase genotype-guided fluoropyrimidine dosing on chemotherapy associated adverse events.
Wigle, Theodore J; Povitz, Brandi L; Medwid, Samantha; Teft, Wendy A; Legan, Robin M; Lenehan, John; Nevison, Stephanie; Panuganty, Veera; Keller, Denise; Mailloux, Jaymie; Siebring, Victoria; Sarma, Sisira; Choi, Yun-Hee; Welch, Stephen; Winquist, Eric; Schwarz, Ute I; Kim, Richard B.
Afiliación
  • Wigle TJ; Department of Physiology and Pharmacology, University of Western Ontario, London, Canada.
  • Povitz BL; Lawson Health Research Institute, London, Canada.
  • Medwid S; Department of Physiology and Pharmacology, University of Western Ontario, London, Canada.
  • Teft WA; Department of Medicine, University of Western Ontario, London, Canada.
  • Legan RM; Department of Medicine, University of Western Ontario, London, Canada.
  • Lenehan J; Department of Medicine, University of Western Ontario, London, Canada.
  • Nevison S; Department of Oncology, University of Western Ontario, London, Canada.
  • Panuganty V; School of Medicine, University of Toronto, Mississauga, Canada.
  • Keller D; Department of Oncology, University of Western Ontario, London, Canada.
  • Mailloux J; London Health Sciences Centre, London, Canada.
  • Siebring V; Department of Physiology and Pharmacology, University of Western Ontario, London, Canada.
  • Sarma S; Department of Medicine, University of Western Ontario, London, Canada.
  • Choi YH; London Health Sciences Centre, London, Canada.
  • Welch S; Department of Epidemiology and Biostatistics, University of Western Ontario, London, Canada.
  • Winquist E; Department of Epidemiology and Biostatistics, University of Western Ontario, London, Canada.
  • Schwarz UI; Department of Oncology, University of Western Ontario, London, Canada.
  • Kim RB; Department of Oncology, University of Western Ontario, London, Canada.
Clin Transl Sci ; 14(4): 1338-1348, 2021 07.
Article en En | MEDLINE | ID: mdl-33620159

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dihidrouracilo Deshidrogenasa (NADP) / Deficiencia de Dihidropirimidina Deshidrogenasa / Neoplasias / Antimetabolitos Antineoplásicos Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Clin Transl Sci Año: 2021 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dihidrouracilo Deshidrogenasa (NADP) / Deficiencia de Dihidropirimidina Deshidrogenasa / Neoplasias / Antimetabolitos Antineoplásicos Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Clin Transl Sci Año: 2021 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos